Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ahmed Fouad, Mady"'
Autor:
Ahmed Fouad Mady, Mohammed Ali Al-Odat, Rayan Alshaya, Sahar Hussien, Ahmed Aletreby, Hend Mohammed Hamido, Waleed Tharwat Aletreby
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 11, Iss 2, Pp 143-149 (2023)
Background: ICU readmission is associated with poor outcomes. Few studies have directly compared the outcomes of early versus late readmissions, especially in Saudi Arabia. Objective: To compare the outcomes between early and late ICU readmissions, m
Externí odkaz:
https://doaj.org/article/dc11d700c810407e9368acad05662cda
Autor:
Waleed Tharwat Aletreby, Shahzad Ahmad Mumtaz, Saima Akhtar Shahzad, Intekhab Ahmed, Mohammed Ali Alodat, Mohamed Gharba, Zohdi Ahmed Farea, Ahmed Fouad Mady, Waqas Mahmood, Huda Mhawish, Majd Munia Abdulmowla, Rehab Mohammed Nasser
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 10, Iss 1, Pp 19-24 (2022)
Background: ISARIC mortality score is a risk stratification tool that helps predict the in-hospital mortality of COVID-19 patients. However, this tool was developed and validated in a British population, and thus, the external validation of this tool
Externí odkaz:
https://doaj.org/article/3e0f8e0ff2f14f51b36e101f6092089c
Autor:
Gultakin Hasan Bakirova, Abdulrahman Alharthy, Silvia Corcione, Waleed Tharwat Aletreby, Ahmed Fouad Mady, Francesco Giuseppe De Rosa, Dimitrios Karakitsos
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-4 (2020)
Abstract Introduction Edwardsiella tarda uncommonly infects humans. The usual presentation is mild gastroenteritis, but systemic manifestations may occur. Lethal infections are rarely documented in patients with underlying disorders. Case presentatio
Externí odkaz:
https://doaj.org/article/2316a63c014c4cf2960631e36ab4f7f6
Autor:
Riyazuddin S. H. Ansari, Ahmed Fouad Mady, Hatem Othman Qutub, Eidah Althomaly, Zainab Abdulaziz Alzayer, Amna A. R. Moulana
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 26, Iss 1, Pp 125-127 (2015)
Metformin is a first-line oral anti-hyperglycemic agent. It decreases insulin resistance, decreases hepatic glucose output and enhances peripheral glucose uptake. Metformin is used as a monotherapy in combination with other oral hypoglycemic agents.
Externí odkaz:
https://doaj.org/article/dfa466a3e0de4cb9bafeb2b47ef99e0b
Autor:
Ahmed Fouad Mady, Waleed Tharwat Aletreby, Omar Elsayed Ramadan, Mohammed Ali Alodat, Abdulrahman Mishaal Alharthy, Dimitrios Karakitsos
Publikováno v:
Journal of Anesthesia and Critical Care: Open access. 12:200-204
Liver transplantation has gone through significant improvement since its start early last century. Which resulted in an increased demand unmatched by availability of donors, hence, several new approaches were devised to maintain an adequate supply of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a38bbecf8d167c3e5ba34165602c813c
https://doi.org/10.15406/jaccoa.2020.12.00460
https://doi.org/10.15406/jaccoa.2020.12.00460
Autor:
Muhammad Asim Rana, Ahmed Fouad Mady, Basheer Abdel Rehman, Abdulrahman Alharthy, Basim Huwait, Asim Riaz, Waleed Tharwat Aletreby
Publikováno v:
Case Reports in Critical Care, Vol 2015 (2015)
Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension. It has been reported to cause systemic side effects especially in elderly patients wi
Externí odkaz:
https://doaj.org/article/818f1c4f65b8452e8b501a83f313cded
Autor:
Muhammad Asim Rana, Basheer Abd El Rahaman, Ahmed Fouad Mady, Mohammed Al Odat, Abdurehman Al Harthy, Omar El Sayed Ramadan, Shehzad Ahmad Mumtaz, Ali S. Omrani
Publikováno v:
Infectious Disease Reports, Vol 6, Iss 3 (2014)
Infections caused by carbapenem-resistant, Gram-negative bacteria are an increasing clinical challenge, since the antimicrobial treatment options are often limited to colistin methanesulfonate. No data are available regarding the pharmacokinetics of
Externí odkaz:
https://doaj.org/article/b7a294aca2e94ac69cfb587fa36a0856
Autor:
Eidah Althomaly, Zainab Abdulaziz Alzayer, Hatem Othman Qutub, Ahmed Fouad Mady, Riyazuddin S. Ansari, Amna A. R. Moulana
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 26, Iss 1, Pp 125-127 (2015)
Metformin is a first-line oral anti-hyperglycemic agent. It decreases insulin resistance, decreases hepatic glucose output and enhances peripheral glucose uptake. Metformin is used as a monotherapy in combination with other oral hypoglycemic agents.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed635b3af4a09807783eabe567a2bbcd
http://www.sjkdt.org/article.asp?issn=1319-2442
http://www.sjkdt.org/article.asp?issn=1319-2442